Concepts (188)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Outpatients | 2 | 2022 | 463 | 1.260 |
Why?
|
| Intellectual Disability | 12 | 2024 | 1065 | 1.030 |
Why?
|
| Neurodevelopmental Disorders | 8 | 2024 | 464 | 1.030 |
Why?
|
| Bacteriophage T4 | 1 | 2020 | 9 | 0.710 |
Why?
|
| Medicaid | 1 | 2022 | 306 | 0.680 |
Why?
|
| Genetic Testing | 6 | 2024 | 1696 | 0.670 |
Why?
|
| Myopathies, Nemaline | 1 | 2018 | 8 | 0.650 |
Why?
|
| Tuberous Sclerosis | 1 | 2020 | 145 | 0.630 |
Why?
|
| Pedigree | 5 | 2023 | 2042 | 0.620 |
Why?
|
| Viral Proteins | 1 | 2020 | 491 | 0.570 |
Why?
|
| Troponin T | 1 | 2018 | 258 | 0.560 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2018 | 230 | 0.560 |
Why?
|
| Heterozygote | 3 | 2020 | 1056 | 0.500 |
Why?
|
| Genes, BRCA2 | 1 | 2016 | 322 | 0.460 |
Why?
|
| Haploinsufficiency | 3 | 2021 | 301 | 0.450 |
Why?
|
| Genes, BRCA1 | 1 | 2016 | 397 | 0.440 |
Why?
|
| Gene Deletion | 1 | 2018 | 1474 | 0.440 |
Why?
|
| Mutation | 10 | 2022 | 15912 | 0.440 |
Why?
|
| Craniofacial Abnormalities | 3 | 2020 | 250 | 0.430 |
Why?
|
| Developmental Disabilities | 3 | 2023 | 697 | 0.400 |
Why?
|
| Mutation, Missense | 6 | 2021 | 1192 | 0.400 |
Why?
|
| Genetic Association Studies | 4 | 2020 | 1099 | 0.380 |
Why?
|
| Sequence Deletion | 4 | 2020 | 909 | 0.370 |
Why?
|
| DNA-Binding Proteins | 3 | 2021 | 5002 | 0.360 |
Why?
|
| Phenotype | 12 | 2023 | 6509 | 0.310 |
Why?
|
| Adenosine Triphosphatases | 2 | 2020 | 427 | 0.300 |
Why?
|
| Alleles | 5 | 2020 | 2600 | 0.280 |
Why?
|
| Seizures | 2 | 2024 | 1001 | 0.270 |
Why?
|
| Autism Spectrum Disorder | 2 | 2022 | 377 | 0.260 |
Why?
|
| Chaperonin Containing TCP-1 | 1 | 2024 | 18 | 0.240 |
Why?
|
| Abnormalities, Multiple | 3 | 2021 | 1023 | 0.240 |
Why?
|
| Histones | 3 | 2022 | 1513 | 0.230 |
Why?
|
| Exons | 2 | 2018 | 1383 | 0.220 |
Why?
|
| Protein Folding | 1 | 2024 | 297 | 0.220 |
Why?
|
| Goldenhar Syndrome | 1 | 2023 | 14 | 0.220 |
Why?
|
| Counselors | 1 | 2023 | 27 | 0.220 |
Why?
|
| Cultural Competency | 1 | 2023 | 70 | 0.210 |
Why?
|
| Dwarfism | 2 | 2020 | 110 | 0.200 |
Why?
|
| Laboratories | 1 | 2023 | 132 | 0.200 |
Why?
|
| Vulnerable Populations | 1 | 2024 | 187 | 0.200 |
Why?
|
| Child | 13 | 2024 | 30559 | 0.200 |
Why?
|
| Micrognathism | 1 | 2021 | 68 | 0.190 |
Why?
|
| Chromosome Disorders | 1 | 2023 | 423 | 0.190 |
Why?
|
| Hand Deformities, Congenital | 1 | 2021 | 95 | 0.190 |
Why?
|
| Genetic Counseling | 1 | 2023 | 417 | 0.180 |
Why?
|
| Hyperostosis, Cortical, Congenital | 1 | 2020 | 3 | 0.180 |
Why?
|
| Texas | 2 | 2022 | 6449 | 0.180 |
Why?
|
| Microcephaly | 3 | 2020 | 333 | 0.180 |
Why?
|
| Calcineurin | 1 | 2021 | 130 | 0.180 |
Why?
|
| Humans | 35 | 2024 | 270740 | 0.180 |
Why?
|
| Transcription Factors, General | 1 | 2020 | 10 | 0.180 |
Why?
|
| Loss of Function Mutation | 1 | 2021 | 165 | 0.170 |
Why?
|
| Hypocalcemia | 1 | 2020 | 59 | 0.170 |
Why?
|
| Hydrolysis | 1 | 2020 | 237 | 0.170 |
Why?
|
| Penetrance | 1 | 2020 | 134 | 0.170 |
Why?
|
| Hospitals | 1 | 2023 | 484 | 0.170 |
Why?
|
| Exodeoxyribonucleases | 1 | 2020 | 109 | 0.170 |
Why?
|
| Leigh Disease | 1 | 2019 | 32 | 0.170 |
Why?
|
| Neurofibromin 1 | 1 | 2019 | 84 | 0.160 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2020 | 459 | 0.160 |
Why?
|
| Growth Disorders | 1 | 2020 | 223 | 0.160 |
Why?
|
| Aorta, Thoracic | 1 | 2023 | 534 | 0.150 |
Why?
|
| Skull | 1 | 2020 | 251 | 0.150 |
Why?
|
| Thrombocytopenia | 1 | 2023 | 870 | 0.150 |
Why?
|
| Eye Abnormalities | 1 | 2018 | 112 | 0.150 |
Why?
|
| Neurofibromatosis 1 | 1 | 2019 | 159 | 0.150 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2021 | 376 | 0.150 |
Why?
|
| Adenosine Triphosphate | 1 | 2020 | 584 | 0.150 |
Why?
|
| Mediator Complex | 1 | 2018 | 67 | 0.150 |
Why?
|
| Glaucoma | 1 | 2018 | 103 | 0.150 |
Why?
|
| Cardiomyopathies | 1 | 2023 | 552 | 0.150 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 628 | 0.140 |
Why?
|
| Cellular Senescence | 1 | 2019 | 388 | 0.140 |
Why?
|
| Antigens, Nuclear | 1 | 2017 | 126 | 0.140 |
Why?
|
| CDC2 Protein Kinase | 1 | 2017 | 188 | 0.140 |
Why?
|
| Protein Binding | 2 | 2021 | 3485 | 0.140 |
Why?
|
| Craniosynostoses | 1 | 2018 | 134 | 0.140 |
Why?
|
| Language Development Disorders | 1 | 2017 | 166 | 0.130 |
Why?
|
| Motor Activity | 1 | 2020 | 699 | 0.130 |
Why?
|
| Homozygote | 1 | 2018 | 772 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2020 | 5776 | 0.130 |
Why?
|
| Binding Sites | 1 | 2020 | 2255 | 0.130 |
Why?
|
| Male | 18 | 2024 | 128315 | 0.130 |
Why?
|
| Child, Preschool | 10 | 2024 | 17061 | 0.130 |
Why?
|
| Face | 1 | 2017 | 252 | 0.130 |
Why?
|
| Models, Molecular | 1 | 2020 | 1741 | 0.120 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2020 | 1503 | 0.120 |
Why?
|
| Exome | 4 | 2024 | 1248 | 0.120 |
Why?
|
| Transcription Factors | 2 | 2020 | 5438 | 0.120 |
Why?
|
| Facies | 3 | 2023 | 160 | 0.120 |
Why?
|
| Brain | 2 | 2024 | 4208 | 0.110 |
Why?
|
| Female | 15 | 2024 | 148940 | 0.110 |
Why?
|
| Escherichia coli | 1 | 2020 | 1305 | 0.110 |
Why?
|
| Retrospective Studies | 5 | 2023 | 39890 | 0.110 |
Why?
|
| Infant | 5 | 2020 | 13999 | 0.110 |
Why?
|
| Epilepsy | 1 | 2021 | 931 | 0.110 |
Why?
|
| Amino Acid Substitution | 3 | 2020 | 657 | 0.100 |
Why?
|
| Adult | 9 | 2024 | 82040 | 0.100 |
Why?
|
| Zebrafish | 3 | 2020 | 457 | 0.100 |
Why?
|
| Amino Acid Sequence | 1 | 2018 | 4567 | 0.100 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 2573 | 0.100 |
Why?
|
| DNA | 1 | 2020 | 3050 | 0.100 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 1286 | 0.100 |
Why?
|
| Phosphoproteins | 1 | 2016 | 1138 | 0.090 |
Why?
|
| Syndrome | 3 | 2019 | 1407 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 1581 | 0.090 |
Why?
|
| Neoplasms | 1 | 2016 | 15927 | 0.090 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 1470 | 0.080 |
Why?
|
| Adolescent | 7 | 2024 | 32767 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 7381 | 0.070 |
Why?
|
| HEK293 Cells | 2 | 2021 | 1461 | 0.070 |
Why?
|
| Incidence | 1 | 2016 | 5824 | 0.070 |
Why?
|
| Heart Defects, Congenital | 1 | 2017 | 1795 | 0.060 |
Why?
|
| United States | 1 | 2022 | 15861 | 0.060 |
Why?
|
| Aged | 3 | 2024 | 73333 | 0.060 |
Why?
|
| Neurons | 3 | 2022 | 2439 | 0.060 |
Why?
|
| Protein Subunits | 1 | 2024 | 278 | 0.060 |
Why?
|
| Facial Asymmetry | 1 | 2023 | 21 | 0.050 |
Why?
|
| Medically Underserved Area | 1 | 2024 | 123 | 0.050 |
Why?
|
| Chromosome Breakage | 1 | 2023 | 225 | 0.050 |
Why?
|
| Dilatation | 1 | 2023 | 87 | 0.050 |
Why?
|
| Caenorhabditis elegans | 1 | 2024 | 280 | 0.050 |
Why?
|
| Gene Expression | 2 | 2021 | 3640 | 0.050 |
Why?
|
| Animals | 6 | 2023 | 61956 | 0.050 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2021 | 13 | 0.050 |
Why?
|
| Middle Aged | 5 | 2024 | 90352 | 0.050 |
Why?
|
| Frameshift Mutation | 1 | 2022 | 234 | 0.050 |
Why?
|
| Autistic Disorder | 1 | 2024 | 354 | 0.050 |
Why?
|
| Protein Domains | 1 | 2022 | 322 | 0.050 |
Why?
|
| Proteome | 1 | 2024 | 571 | 0.050 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2023 | 530 | 0.050 |
Why?
|
| Mitochondrial Proteins | 1 | 2023 | 379 | 0.040 |
Why?
|
| Hypoparathyroidism | 1 | 2020 | 49 | 0.040 |
Why?
|
| Muscle Hypotonia | 1 | 2021 | 188 | 0.040 |
Why?
|
| Osteochondrodysplasias | 1 | 2020 | 75 | 0.040 |
Why?
|
| Organogenesis | 1 | 2020 | 100 | 0.040 |
Why?
|
| Electron Transport | 1 | 2019 | 78 | 0.040 |
Why?
|
| Electron Transport Complex IV | 1 | 2019 | 55 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 2023 | 1655 | 0.040 |
Why?
|
| Cell Nucleolus | 1 | 2019 | 101 | 0.040 |
Why?
|
| Actins | 1 | 2021 | 602 | 0.040 |
Why?
|
| Zebrafish Proteins | 1 | 2019 | 155 | 0.040 |
Why?
|
| Family | 1 | 2023 | 783 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2023 | 617 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 8 | 1 | 2018 | 19 | 0.040 |
Why?
|
| Organ Size | 1 | 2020 | 692 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2023 | 763 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2024 | 9470 | 0.040 |
Why?
|
| Transcription Initiation, Genetic | 1 | 2018 | 12 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2024 | 1017 | 0.040 |
Why?
|
| Nuclear Family | 1 | 2018 | 68 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2024 | 1654 | 0.040 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2021 | 217 | 0.040 |
Why?
|
| Aneuploidy | 1 | 2019 | 382 | 0.040 |
Why?
|
| Young Adult | 3 | 2024 | 22251 | 0.040 |
Why?
|
| United Kingdom | 1 | 2018 | 287 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 831 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 676 | 0.040 |
Why?
|
| Nerve Net | 1 | 2020 | 272 | 0.040 |
Why?
|
| Axons | 1 | 2020 | 441 | 0.030 |
Why?
|
| Larva | 1 | 2017 | 293 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 30998 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2020 | 623 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2020 | 7238 | 0.030 |
Why?
|
| Mice | 3 | 2023 | 35600 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2024 | 7895 | 0.030 |
Why?
|
| Transcriptome | 1 | 2024 | 1963 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2018 | 579 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 295 | 0.030 |
Why?
|
| Gene Editing | 1 | 2017 | 229 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2023 | 1718 | 0.030 |
Why?
|
| Mothers | 1 | 2018 | 416 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2017 | 362 | 0.030 |
Why?
|
| Chromatin | 1 | 2019 | 1046 | 0.030 |
Why?
|
| Rats | 1 | 2022 | 6441 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2018 | 991 | 0.030 |
Why?
|
| Genomics | 1 | 2024 | 2835 | 0.030 |
Why?
|
| Cell Movement | 1 | 2020 | 2472 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2023 | 2928 | 0.030 |
Why?
|
| Genotype | 1 | 2020 | 4252 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2022 | 4130 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2016 | 2357 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2020 | 6390 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 4492 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2017 | 5694 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2019 | 2765 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 2359 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 7783 | 0.010 |
Why?
|